Envestnet Asset Management Inc Red Hill Biopharma Ltd. Transaction History

Envestnet Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.14 - $695.9 $6,371 - $31.7 Million	45,512 Added 182.05%	70,512 $9,000
Q3 2022 Nov 10, 2022	BUY	$0.5 - $523.8 $12,500 - $13.1 Million	25,000 New	25,000 $13,000
Q4 2021 Feb 04, 2022	SELL	$2.31 - $5.85 $178,431 - $451,871	-77,243 Closed	0 $0
Q3 2021 Oct 07, 2021	BUY	$4.55 - $10.36 $351,455 - $800,237	77,243 New	77,243 $354,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $557M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.